How much funding has Coagulant Therapeutics raised?

Coagulant Therapeutics has raised $7.8M in total funding, most recently a Venture Round.

Who are Coagulant Therapeutics's investors?

Coagulant Therapeutics's investors include IMM Investment.

Coagulant Therapeutics operates in Biotech, Healthcare.

Biotech firm developing acute bleeding and coagulation-targeted therapeutics.

Summary

Coagulant Therapeutics is a Biotech company. It has raised $7.8M in total across 1 round. Investors include IMM Investment.

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

$7.8M

Unknown

IMM Investment

1 round

China's leading blood products manufacturer

Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Biopharmaceutical services company

Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company